xLM Enables Omniscient’s Breakthrough in Brain Mapping with FDA 510(k) domain

Omniscient leveraged xLM’s Continuous Validation services to achieve FDA 510(k) clearance for Quicktome, a brain mapping SaMD. xLM ensured AWS compliance and streamlined validation, accelerating approval. This partnership enabled Omniscient to revolutionize brain care, providing neurosurgeons with cutting-edge insights into neurological diseases and enhancing surgical decision-making worldwide.

xLM Enables Omniscient’s Breakthrough in Brain Mapping with FDA 510(k) domain

Omniscient leveraged xLM’s Continuous Validation services to achieve FDA 510(k) clearance for Quicktome, a brain mapping SaMD. xLM ensured AWS compliance and streamlined validation, accelerating approval. This partnership enabled Omniscient to revolutionize brain care, providing neurosurgeons with cutting-edge insights into neurological diseases and enhancing surgical decision-making worldwide.

Revolutionizing Brain Care with Advanced Technology

Omniscient is leading the charge in transforming brain care by offering unparalleled insights into neuropathology. Through cutting-edge brain mapping and connectomic analyses, Omniscient’s software equips healthcare professionals with a profound understanding of neurological diseases, mental health conditions, and complex neural networks.

The Challenge: Ensuring Compliance for FDA Submission

As Omniscient developed Quicktome, its inaugural software medical device (SaMD), the company encountered a significant challenge—achieving FDA compliance for 510(k) clearance. Due to the complexity of Quicktome, a sophisticated brain mapping platform aimed at enhancing neurosurgical decision-making, Omniscient sought a partner with extensive expertise in:

  • Qualification of AWS infrastructure for regulatory compliance
  • Validation of Software as a Medical Device (SaMD) under stringent FDA guidelines
  • Navigating the regulatory landscape to secure their first 510(k) approval

The Solution: xLM’s Continuous Qualification and Validation Services

Recognizing the urgency of Omniscient’s needs, xLM implemented its Continuous Validation managed service, providing:

  • Continuous Qualification for AWS Cloud Infrastructure: Ensuring compliance with FDA requirements while upholding system integrity and security.
  • End-to-End Validation of Quicktome SaMD: Utilizing automation to streamline validation processes, minimize errors, and expedite time-to-market.

The Results: Fast-Tracked FDA Clearance

By harnessing xLM’s expertise, Omniscient achieved a remarkable milestone:

  • Successfully qualified AWS infrastructure to meet compliance standards
  • Validated Quicktome efficiently and within stringent timelines
  • Secured FDA 510(k) clearance in record time for a complex application

Through this collaboration, Omniscient not only fulfilled regulatory requirements but also established itself as a leader in innovative brain mapping solutions. With Quicktome now accessible to neurosurgeons globally, the company continues to expand the horizons of what is achievable in brain care.

‍